A PYMNTS Company

Germany: Bayer makes big pharma buyout

By  |  May 20, 2013

Pharmaceutical giant Bayer has announced plans to buy 100 percent of Germany-based private pharmaceutical conglomerate Steigerwalk Arzneimittelwerk. Financial details of the deal were not released in a press release; the parties expect to close the deal by July 2013, though it remains subject to approval by antitrust regulators. According to Bayer, the move is part of a larger agenda to promote “organic growth” and expand its product offering for consumers. According to a press release, the move will also expand business for Bayer throughout Germany and east-central Europe.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Pharmiweb

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.